0001734768-20-000002.txt : 20200518 0001734768-20-000002.hdr.sgml : 20200518 20200518145508 ACCESSION NUMBER: 0001734768-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 EFFECTIVENESS DATE: 20200518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMV Inc. CENTRAL INDEX KEY: 0001734768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367193 FILM NUMBER: 20889022 BUSINESS ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 BUSINESS PHONE: 9024921819 MAIL ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 FORMER COMPANY: FORMER CONFORMED NAME: Immunovaccine Inc. DATE OF NAME CHANGE: 20180316 D 1 primary_doc.xml X0708 D LIVE 0001734768 IMV Inc. 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 NOVA SCOTIA, CANADA B3B 2C4 9024921819 CANADA (FEDERAL LEVEL) Rhino Resources Inc. Immunovaccine Inc. Corporation true Frederic Ors 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Executive Officer Director Pierre Labbe 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Executive Officer Andrew Sheldon 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Julia P. Gregory 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director James Hall 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Wayne Pisano 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Shermaine Tilley 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Markus Warmuth 130 Eileen Stubbs Avenue Suite 19 Dartmouth A5 NOVA SCOTIA, CANADA B3B 2C4 Director Pharmaceuticals $1 - $1,000,000 06b false 2020-05-07 true true true true true Each Unit is comprised of one common share and 0.35 common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$3.72 per share until May 7, 2022. false 0 11714982 3567607 8147375 The additional $8,147,375 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. The U.S. dollar amount is based on the Bank of Canada daily average rate of exchange reported on 5/7/20, which was Cdn$1.4015=USD$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false IMV Inc. Pierre Labbe Pierre Labbe Chief Financial Officer 2020-05-12